Illuminating drug discovery with biological pathways

被引:82
|
作者
Apic, G
Ignjatovic, T
Boyer, S
Russell, RB
机构
[1] Cambridge Cell Networks, Cambridge CB3 0FD, England
[2] AstraZeneca R&D, Safety Assessment, S-43183 Molndal, Sweden
[3] EMBL, D-69112 Heidelberg, Germany
关键词
systems biology; drug discovery; biological pathways;
D O I
10.1016/j.febslet.2005.02.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systems biology promises to impact significantly on the drug discovery process. One of its ultimate goals is to provide an understanding of the complete set of molecular mechanisms describing an organism. Although this goal is a long way off, many useful insights can already come from currently available information and technology. One of the biggest challenges in drug discovery today is the high attrition rate: many promising candidates prove ineffective or toxic owing to a poor understanding of the molecular mechanisms of biological systems they target. A "systems" approach can help identify pathways related to a disease and can suggest secondary effects of drugs that might cause these problems and thus ultimately improve the drug discovery pipeline. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1872 / 1877
页数:6
相关论文
共 50 条
  • [21] Ligandomics: a paradigm shift in biological drug discovery
    Li, Wei
    Pang, Iok-Hou
    Pacheco, Mario Thiego F.
    Tian, Hong
    DRUG DISCOVERY TODAY, 2018, 23 (03) : 636 - 643
  • [22] Integrated Computational Analysis of Physicochemical Features, Biological Properties, Kinase Target Prediction and Biotransformation Pathways in Drug Discovery
    Bensaad, Mohamed Sabri
    Bensaad, Dhiya Eddine
    Kahoul, Mohamed Amine
    Waggas, Dania S.
    Baty, Roua S.
    Sami, Rokayya
    Banjer, Hamsa Jameel
    Alharthi, Siraj B.
    Bedaiwi, Ruqaiah I.
    Alharbi, Zeyad M.
    Alanazi, Mohammad A.
    Alsubhi, Nouf H.
    Al-Nazawi, Ashwaq M.
    Alqadri, Nada
    Al-Harthi, Helal F.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2024, 20 (05) : 748 - 767
  • [23] Exploiting marine actinomycete biosynthetic pathways for drug discovery
    Bradley S. Moore
    John A. Kalaitzis
    Longkuan Xiang
    Antonie van Leeuwenhoek, 2005, 87 : 49 - 57
  • [24] New pathways in drug discovery for alzheimer’s disease
    Eric R. Siemers
    Robert A. Dean
    Ronald Demattos
    Patrick C. May
    Current Neurology and Neuroscience Reports, 2006, 6 : 372 - 378
  • [25] Fibrosis, chronic inflammation and new pathways for drug discovery
    Sivakumar, P.
    Das, A. M.
    INFLAMMATION RESEARCH, 2008, 57 (09) : 410 - 418
  • [26] Fibrosis, chronic inflammation and new pathways for drug discovery
    P. Sivakumar
    A. M. Das
    Inflammation Research, 2008, 57 : 410 - 418
  • [27] New pathways in drug discovery for Alzheimer's disease
    Siemers, Eric R.
    Dean, Robert A.
    Demattos, Ronald
    May, Patrick C.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2006, 6 (05) : 372 - 378
  • [28] Exploiting marine actinomycete biosynthetic pathways for drug discovery
    Moore, BS
    Kalaitzis, JA
    Xiang, LK
    ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, 2005, 87 (01): : 49 - 57
  • [29] Illuminating zinc in biological systems
    Lim, NC
    Freake, HC
    Brückner, C
    CHEMISTRY-A EUROPEAN JOURNAL, 2005, 11 (01) : 38 - 49
  • [30] Via: Illuminating Academic Pathways at Scale
    Angus, Geoffrey
    Martinez, Richard Diehl
    Stevens, Mitchell L.
    Paepcke, Andreas
    L@S '19: PROCEEDINGS OF THE SIXTH (2019) ACM CONFERENCE ON LEARNING @ SCALE, 2019,